These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7809822)

  • 1. Integrin expression in primary breast cancer and its relation to axillary nodal status.
    Gui GP; Wells CA; Browne PD; Yeomans P; Jordan S; Puddefoot JR; Vinson GP; Carpenter R
    Surgery; 1995 Jan; 117(1):102-8. PubMed ID: 7809822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrin expression and survival in human breast cancer.
    Berry MG; Gui GP; Wells CA; Carpenter R
    Eur J Surg Oncol; 2004 Jun; 30(5):484-9. PubMed ID: 15135474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin expression in breast cancer cytology: a novel predictor of axillary metastasis.
    Gui GP; Wells CA; Yeomans P; Jordan SE; Vinson GP; Carpenter R
    Eur J Surg Oncol; 1996 Jun; 22(3):254-8. PubMed ID: 8654607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting axillary sentinel node status in patients with primary breast cancer.
    Kolarik D; Pecha V; Skovajsova M; Zahumensky J; Trnkova M; Petruzelka L; Halaska M; Sottner O; Otcenasek M; Kolarova H
    Neoplasma; 2013; 60(3):334-42. PubMed ID: 23374005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomograms for preoperative prediction of axillary nodal status in breast cancer.
    Dihge L; Bendahl PO; Rydén L
    Br J Surg; 2017 Oct; 104(11):1494-1505. PubMed ID: 28718896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Primary Breast Tumor Location on Axillary Nodal Positivity.
    Desai AA; Hoskin TL; Day CN; Habermann EB; Boughey JC
    Ann Surg Oncol; 2018 Oct; 25(10):3011-3018. PubMed ID: 29968027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the likelihood of additional nodal metastases in breast carcinoma patients with positive sentinel node biopsy.
    Mustać E; Matusan-Ilijas K; Marijić B; Smokvina M; Jonjić N
    Int J Surg Pathol; 2010 Feb; 18(1):36-41. PubMed ID: 19448065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and Predictors of Axillary Lymph Node Metastases in Iranian Women with Early Breast Cancer.
    Sandoughdaran S; Malekzadeh M; Mohammad Esmaeil ME
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1617-1620. PubMed ID: 29936787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors for extensive nodal involvement in breast cancer patients with axillary lymph node metastases.
    Verheuvel NC; Ooms HW; Tjan-Heijnen VC; Roumen RM; Voogd AC
    Breast; 2016 Jun; 27():175-81. PubMed ID: 27123958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients.
    Kwon Y; Ro J; Kang HS; Kim SK; Hong EK; Khang SK; Gong G; Ro JY
    Oncol Rep; 2011 Apr; 25(4):1063-71. PubMed ID: 21258771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancer.
    Van den Eynden GG; Van der Auwera I; Van Laere SJ; Huygelen V; Colpaert CG; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA
    Br J Cancer; 2006 Nov; 95(10):1362-6. PubMed ID: 17088912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-Enhanced Ultrasound Biopsy of Sentinel Lymph Nodes in Patients with Breast Cancer: Implications for Axillary Metastases and Conservation.
    Cox K; Weeks J; Mills P; Chalmers R; Devalia H; Fish D; Sever A
    Ann Surg Oncol; 2016 Jan; 23(1):58-64. PubMed ID: 25990967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Predictive Model for Axillary Node Pathologic Complete Response after Neoadjuvant Chemotherapy for Breast Cancer.
    Kantor O; Sipsy LM; Yao K; James TA
    Ann Surg Oncol; 2018 May; 25(5):1304-1311. PubMed ID: 29368152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Egfl7 correlates with low-grade invasive lesions in human breast cancer.
    Philippin-Lauridant G; Baranzelli MC; Samson C; Fournier C; Pinte S; Mattot V; Bonneterre J; Soncin F
    Int J Oncol; 2013 Apr; 42(4):1367-75. PubMed ID: 23404186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical observations of axillary involvement for tubular, lobular, and ductal carcinomas of the breast.
    Leonard CE; Philpott P; Shapiro H; Corkill M; Gonzales C; Ponce J; Howell K; Aarestad N; Sedlacek SM
    J Surg Oncol; 1999 Jan; 70(1):13-20. PubMed ID: 9989415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of predictors of axillary node metastases in 787 breast cancer patients].
    Zhang B; Zhang XJ; Guo F; Zheng RL; Zhang GC; Han GH; Liang XB; Gao JN
    Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):67-9. PubMed ID: 21575469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of alpha 2 beta 1 integrin expression with histological type and hormonal receptor status in breast carcinomas.
    Lanzafame S; Emmanuele C; Torrisi A
    Pathol Res Pract; 1996 Oct; 192(10):1031-8. PubMed ID: 8958553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation of visualization of internal mammary lymph nodes on lymphoscintigraphy to axillary lymph node metastases in breast cancer.
    Kim H; Shin MJ; Kim SJ; Kim IJ; Park I
    Lymphat Res Biol; 2014 Dec; 12(4):295-300. PubMed ID: 25144255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Correlations with their functions as receptors and cell adhesion molecules.
    Koukoulis GK; Virtanen I; Korhonen M; Laitinen L; Quaranta V; Gould VE
    Am J Pathol; 1991 Oct; 139(4):787-99. PubMed ID: 1928301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of CD44+CD24- cells on non-sentinel axillary lymph node metastases in sentinel node-positive breast cancer.
    Nogi H; Suzuki M; Kamio M; Kato K; Kawase K; Toriumi Y; Takeyama H; Fukushima H; Morikawa T; Uchida K
    Oncol Rep; 2011 Apr; 25(4):1109-15. PubMed ID: 21308353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.